Trust Co. of Toledo NA OH Has $239,000 Holdings in The Clorox Company (NYSE:CLX)

Trust Co. of Toledo NA OH cut its position in The Clorox Company (NYSE:CLX) by 7.1% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,474 shares of the company’s stock after selling 113 shares during the quarter. Trust Co. of Toledo NA OH’s holdings in Clorox were worth $239,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Catalyst Capital Advisors LLC acquired a new position in Clorox in the 3rd quarter valued at $54,000. AQR Capital Management LLC grew its position in Clorox by 8.6% in the 2nd quarter. AQR Capital Management LLC now owns 287,277 shares of the company’s stock worth $39,121,000 after purchasing an additional 22,676 shares during the last quarter. Los Angeles Capital Management LLC grew its position in Clorox by 5.6% in the 3rd quarter. Los Angeles Capital Management LLC now owns 191,919 shares of the company’s stock worth $31,266,000 after purchasing an additional 10,149 shares during the last quarter. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp grew its position in Clorox by 60.5% in the 2nd quarter. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp now owns 23,769 shares of the company’s stock worth $3,244,000 after purchasing an additional 8,957 shares during the last quarter. Finally, Canada Pension Plan Investment Board grew its position in Clorox by 1.6% in the 2nd quarter. Canada Pension Plan Investment Board now owns 353,394 shares of the company’s stock worth $48,228,000 after purchasing an additional 5,500 shares during the last quarter. 78.53% of the stock is currently owned by institutional investors and hedge funds.

Clorox Trading Down 0.2 %

Shares of CLX stock opened at $157.32 on Tuesday. The Clorox Company has a 12-month low of $127.60 and a 12-month high of $171.37. The company has a market capitalization of $19.47 billion, a P/E ratio of 54.82, a P/E/G ratio of 3.04 and a beta of 0.42. The firm has a 50-day moving average price of $164.55 and a 200 day moving average price of $156.00. The company has a quick ratio of 0.62, a current ratio of 1.00 and a debt-to-equity ratio of 11.08.

Clorox (NYSE:CLX) last announced its quarterly earnings results on Wednesday, October 30th. The company reported $1.86 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.36 by $0.50. Clorox had a net margin of 4.78% and a return on equity of 316.08%. The firm had revenue of $1.76 billion during the quarter, compared to the consensus estimate of $1.64 billion. During the same period last year, the firm posted $0.49 EPS. The firm’s quarterly revenue was up 27.0% on a year-over-year basis. Research analysts forecast that The Clorox Company will post 6.85 earnings per share for the current fiscal year.

Clorox Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Wednesday, January 29th will be given a $1.22 dividend. This represents a $4.88 annualized dividend and a yield of 3.10%. The ex-dividend date is Wednesday, January 29th. Clorox’s payout ratio is presently 170.03%.

Analyst Upgrades and Downgrades

Several analysts have issued reports on CLX shares. StockNews.com lowered shares of Clorox from a “buy” rating to a “hold” rating in a research report on Sunday, January 5th. DA Davidson raised their price target on shares of Clorox from $153.00 to $171.00 and gave the stock a “neutral” rating in a research report on Monday, November 4th. Barclays raised their price objective on shares of Clorox from $137.00 to $139.00 and gave the stock an “underweight” rating in a report on Friday, November 1st. JPMorgan Chase & Co. raised their price objective on shares of Clorox from $148.00 to $174.00 and gave the stock a “neutral” rating in a report on Friday, October 11th. Finally, Jefferies Financial Group raised shares of Clorox from a “hold” rating to a “buy” rating and raised their price objective for the stock from $174.00 to $187.00 in a report on Tuesday, October 1st. Four investment analysts have rated the stock with a sell rating, ten have assigned a hold rating and one has given a buy rating to the company. According to data from MarketBeat.com, the company has an average rating of “Hold” and a consensus target price of $157.46.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.